On July 13, Definium Therapeutics fell 5.44% in regular trading, trading at $44.45 USD/share, with Turnover of $13.26 million.
Within the Pharmacy sector where Definium Therapeutics belongs, the overall sector performance was mixed. Among individual stocks, Eli Lilly down 0.26%, Pfizer up 1.53%, Johnson & Johnson down 0.07%, Crinetics Pharmaceuticals up 0.05%, AstraZeneca down 1.62%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)